Search

You searched for "OHT"

1985 results found

Newer generation IOL platforms designed for high-quality visual performance after cataract surgery

1 April 2019 | | EYE - Cataract, EYE - Refractive, EYE - General
Expanding intraocular lens (IOL) capabilities provide broadening options, ranging from next-generation monofocal IOLs for basic cataract surgery, to specialised premium IOLs for lens-based presbyopia correction and astigmatism correction at the time of cataract surgery. Rod McNeil considers several newer alternative...

Effective management of dry eye and ocular surface disease

4 August 2021 | | EYE - General
Experts recommend a consistent approach to diagnosis, therapeutic targeting by disease subtype and escalation of therapy when tear substitutes are not sufficient. Experts call for a consistent, unified approach to diagnosis of dry eye disease (DED), with a new simple...

The founder of modern ophthalmology: Sir William Stewart Duke-Elder

2 June 2025 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
A recent article in Eye News by Blaikie & King highlighted the extraordinary contribution made to the profession of ophthalmology by Sir William Stewart Duke-Elder. The author felt it appropriate to take a further in-depth look at the remarkable career...

Personalising the management of dry eye disease: TFOS DEWS III updates evidence-based recommendations

11 June 2026 | | EYE - Cornea, EYE - Oncology
Dry eye disease (DED) is a heterogenous condition that arises from various aetiologic factors and leads to tear film instability, ocular surface damage and neurosensory changes. Symptoms of DED include ocular dryness, burning, itching, pain and visual impairment. An evidence-based...

Immunoglobulin G4-related ophthalmic disease – what is it? (Part 2)

3 April 2023 |
Part 2: Clinical presentation and treatment (see part 1 here) Introduction IgG4-related disease (IgG4-RD) is understood to have a vast clinicopathological spectrum; nearly every organ has had reported involvement. Similarly, IgG4-related ophthalmic disease (IgG4-ROD) is known to affect nearly every...